Literature DB >> 11380823

Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle.

A Blanchard1, X Jeunemaitre, P Coudol, M Dechaux, M Froissart, A May, R Demontis, A Fournier, M Paillard, P Houillier.   

Abstract

BACKGROUND: A new protein, named paracellin 1 (PCLN-1), expressed in human thick ascending limb (TAL) tight junctions, possibly plays a critical role in the control of magnesium and calcium reabsorption, since mutations of PCLN-1 are present in the hypomagnesemia hypercalciuria syndrome (HHS). However, no functional experiments have demonstrated that TAL magnesium and calcium reabsorption were actually impaired in patients with HHS.
METHODS: Genetic studies were performed in the kindred of two unrelated patients with HHS. Renal magnesium and calcium reabsorption in TAL were analyzed in one homozygous affected patient of each family, one patient with extrarenal hypomagnesemia (ERH), and two control subjects (CSs).
RESULTS: We found two yet undescribed mutations of PCLN-1 (Gly 162 Val, Ala 139 Val). In patients with HHS, renal magnesium and calcium reabsorptions were impaired as expected; NaCl renal conservation during NaCl deprivation and NaCl tubular reabsorption in diluting segment were intact. Furosemide infusion in CS markedly increased NaCl, Mg, and Ca urinary excretion rates. In HHS patients, furosemide similarly increased NaCl excretion, but failed to increase Mg and Ca excretion. Acute MgCl(2) infusion in CS and ERH patient provoked a dramatic increase in urinary calcium excretion without change in NaCl excretion. When combined with MgCl(2) infusion, furosemide infusion remained able to induce normal natriuretic response, but was unable to increase urinary magnesium and calcium excretion further. In HHS patients, calciuric response to MgCl(2) infusion was blunted.
CONCLUSION: This study is the first to our knowledge to demonstrate that homozygous mutations of PCLN-1 result in a selective defect in paracellular Mg and Ca reabsorption in the TAL, with intact NaCl reabsorption ability at this site. In addition, the study supports a selective physiological effect of basolateral Mg(2+) and Ca(2+) concentration on TAL divalent cation paracellular permeability, that is, PCLN-1 activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380823     DOI: 10.1046/j.1523-1755.2001.00736.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  46 in total

1.  Epithelial barrier resistance is increased by the divalent cation zinc in cultured MDCKII epithelial monolayers.

Authors:  Georgina Carr; Jamie A Wright; Nicholas L Simmons
Journal:  J Membr Biol       Date:  2010-11-06       Impact factor: 1.843

Review 2.  The influence of extracellular and intracellular calcium on the secretion of renin.

Authors:  Douglas K Atchison; William H Beierwaltes
Journal:  Pflugers Arch       Date:  2012-04-28       Impact factor: 3.657

Review 3.  Magnesium Handling in the Kidney.

Authors:  Joshua N Curry; Alan S L Yu
Journal:  Adv Chronic Kidney Dis       Date:  2018-05       Impact factor: 3.620

Review 4.  Function and regulation of claudins in the thick ascending limb of Henle.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Pflugers Arch       Date:  2008-09-16       Impact factor: 3.657

Review 5.  Biology of claudins.

Authors:  Susanne Angelow; Robert Ahlstrom; Alan S L Yu
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-14

Review 6.  Claudins: control of barrier function and regulation in response to oxidant stress.

Authors:  Christian E Overgaard; Brandy L Daugherty; Leslie A Mitchell; Michael Koval
Journal:  Antioxid Redox Signal       Date:  2011-05-09       Impact factor: 8.401

7.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations.

Authors:  Astrid Godron; Jérôme Harambat; Valérie Boccio; Anne Mensire; Adrien May; Claire Rigothier; Lionel Couzi; Benoit Barrou; Michel Godin; Dominique Chauveau; Stanislas Faguer; Marion Vallet; Pierre Cochat; Philippe Eckart; Geneviève Guest; Vincent Guigonis; Pascal Houillier; Anne Blanchard; Xavier Jeunemaitre; Rosa Vargas-Poussou
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-15       Impact factor: 8.237

8.  Clinical utility gene card for: Familial hypomagnesemia with hypercalciuria and nephrocalcinosis with/without severe ocular involvement.

Authors:  Félix Claverie-Martín; Rosa Vargas-Poussou; Dominik Müller; Víctor García-Nieto
Journal:  Eur J Hum Genet       Date:  2014-09-03       Impact factor: 4.246

9.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations.

Authors:  Ju Hyung Kang; Hyun Jin Choi; Hee Yeon Cho; Joo Hoon Lee; Il Soo Ha; Hae Il Cheong; Yong Choi
Journal:  Pediatr Nephrol       Date:  2005-07-27       Impact factor: 3.714

10.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

Authors:  Jameela A Kari; Mohammed Farouq; Hammad O Alshaya
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.